Analyst upgrades HighPeak Energy to Hold, predicts potential acquisition target status with $13 price target; improved operations and financials noted.
Upgraded to Outperform with $270 price target by RBC analyst due to expected improvement in operating ratio and EPS growth, making NSC an attractive investment opportunity.
GoodRx has been upgraded by RBC Capital Markets due to the growth potential from the Integrated Savings Program, direct contracting initiatives, and manufacturing solutions expansion.
JPMorgan analyst upgrades Hasbro to Overweight with $74 price target, citing cost efficiency and industry trends. Potential for stock to exceed target.